SCHEMBL18018401

SCHEMBL18018401

c1ccc(-c2ccc(-c3nc(-c4cccc(-c5cccc(-c6cccc(-c7cccc(-c8nc(-c9ccc%10ccccc%10c9)c9sc%10ccccc%10c9n8)c7)c6)c5)c4)c4sc5ccccc5c4n3)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LIMK1 P53667 2/20 0.37
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ PIM1 P11309 2/20 0.35
▸ PIM2 Q9P1W9 2/20 0.35
▸ PIM3 Q86V86 1/20 0.35
▸ ADORA2A P29274 2/20 0.35
▸ ADORA1 P30542 2/20 0.35
▸ TNKS O95271 2/20 0.35
▸ TNKS2 Q9H2K2 2/20 0.35
▸ HSD17B1 P14061 1/20 0.35
▸ HSD17B2 P37059 1/20 0.35
▸ HTR2B P41595 1/20 0.34
▸ HTR5A P47898 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16902310 0.99 LIMK1 (0.38) LIMK1MEN1KMT2AKDM4EALDH1A1
SCHEMBL18370239 0.99 LIMK1 (0.38) LIMK1MEN1KMT2AKDM4EALDH1A1
SCHEMBL19497520 0.95 LIMK1 (0.36) LIMK1MEN1KMT2AKDM4EALDH1A1
SCHEMBL16902307 0.95 ADORA2A (0.36) LIMK1MEN1KMT2AKDM4EALDH1A1
SCHEMBL16902380 0.95 ADORA2A (0.36) LIMK1MEN1KMT2AKDM4EALDH1A1
SCHEMBL18017785 0.94 LIMK1 (0.40) LIMK1MEN1KMT2APIM1PIM2
SCHEMBL18017776 0.94 LIMK1 (0.40) LIMK1MEN1KMT2APIM1PIM2
SCHEMBL19106275 0.93 ADORA2A (0.36) LIMK1MEN1KMT2AKDM4EALDH1A1
SCHEMBL18017903 0.93 LIMK1 (0.40) LIMK1MEN1KMT2APIM1PIM2
SCHEMBL18017900 0.93 LIMK1 (0.40) LIMK1MEN1KMT2APIM1PIM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160240791-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2016-08-18 — — US disclosed
US-20160240791-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2016-08-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160240791-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OR10J3, OXER1, OCIAD1 LIMK1 224/4885MEN1 3118/4885KMT2A 4272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback